Cardiovascular adverse effects of anti–IL-5/IL-5Rα therapies: A real-world study
Jean-Baptiste Quinta, François Montastruc, Agnès Sommet, Anthony Touafchia, Michel Galinier, Laurent L. Reber, Vanessa Rousseau, Laurent Guilleminault
Topics & Concepts
OmalizumabMepolizumabMedicineBenralizumabAdverse effectExacerbationAsthmaConfoundingImmunoglobulin ERate ratioAsthma exacerbationsObservational studyIncidence (geometry)Internal medicineImmunologyAntibodyEosinophilPhysicsOpticsConfidence intervalAsthma and respiratory diseasesAllergic Rhinitis and SensitizationUrticaria and Related Conditions